Information Provided By:
Fly News Breaks for March 4, 2020
AGN, EOLS
Mar 4, 2020 | 11:35 EDT
Cantor Fitzgerald analyst Louise Chen noted that Evolus (EOLS) shares were down 9% intraday following headlines from the Korean press related to the company and Daewoong's ongoing ITC case with Allergan (AGN) and Medytox. Following the company's update, and her conversations with management this morning, Chen said she "strongly" believes the negative reaction is overdone and presents a good buying opportunity ahead of what she predicts will be strong sales momentum for Jeuveau in 2020. Chen reiterates an Overweight rating and $35 price target on Evolus shares.
News For EOLS;AGN From the Last 2 Days
EOLS
Apr 22, 2021 | 08:54 EDT
Check out this morning's top movers from around Wall Street, compiled by The Fly.  HIGHER - Renalytix... To see the rest of the story go to thefly.com. See Story Here
EOLS
Apr 21, 2021 | 18:51 EDT
Check out this evening's top movers from around Wall Street, compiled by The Fly. UP AFTER EARNINGSQualtrics... To see the rest of the story go to thefly.com. See Story Here
EOLS
Apr 21, 2021 | 16:02 EDT
SVB Leerink, Stifel and Cantor are acting as joint bookrunning managers for the offering.